Researchclopedia
Research
Researchers
Institutions
Topics
Submit
About
Search...
⌘
K
Command Palette
Search for a command to run...
Back to research
Nivolumab versus sorafenib in advanced hepatocellular carcinoma (CheckMate 459): a randomised, multicentre, open-label, phase 3 trial
2021
1,057 citations
Journal Article
Field-Weighted Citation Impact:
95.51
Nivolumab versus sorafenib in advanced hepatocellular carcinoma (CheckMate 459): a randomised, multicentre, open-label, phase 3 trial | Researchclopedia
·
Hôpital de la Croix-Rousse
Olivier Rosmorduc
Lucjan Wyrwicz
·
The Maria Sklodowska-Curie National Research Institute of Oncology
Eckart Schott
·
Helios Klinikum Emil von Behring
Su Pin Choo
·
National Cancer Centre Singapore
Robin Kate Kelley
·
UCSF Helen Diller Family Comprehensive Cancer Center
Wolfgang Sieghart
Eric Assenat
·
Hôpital Saint Eloi
Renata Zaucha
·
Gdańsk Medical University
Junji Furuse
·
Kyorin University
Ghassan K Abou-Alfa
Anthony B El-Khoueiry
·
University of Southern California
Ignacio Melero
·
Clinica Universidad de Navarra
Damir Begic
·
Bristol-Myers Squibb (United States)
Gong Chen
·
Bristol-Myers Squibb (United States)
Jaclyn Neely
·
Bristol-Myers Squibb (United States)
Tami Wisniewski
·
Bristol-Myers Squibb (United States)
Marina Tschaika
·
Bristol-Myers Squibb (United States)
Bruno Sangro
·
Centro de Investigación Biomédica en Red